ROTH

PharmaRoth Labs, Inc. ROTH

ROTH
PharmaRoth Labs, Inc. DECN
Decision Diagnostics Corp. PRMD
Primemd Inc. SXHHF
Sonomax Technologies Inc WIBFF
West Island Brands Inc. ITMC
Itoco Inc. LGND
Ligand Pharmaceuticals Incorporated MEDD
Medical Imaging Corp. AXMP
AXM Pharma, Inc. AMBS
Amarantus BioScience Holdings, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode ROTH DECN PRMD SXHHF WIBFF ITMC LGND MEDD AXMP AMBS
6M 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 100.00 % 72.17 % 0.00 % 49.25 % -96.67 %
YTD 0.00 % 9 900.00 % 0.00 % 0.00 % 0.00 % -85.71 % 82.59 % 0.00 % 9 900.00 % -90.00 %
1Y 0.00 % 9 900.00 % 0.00 % 0.00 % 0.00 % -85.71 % 73.95 % 0.00 % 9 900.00 % -90.00 %
3Y 1 900.00 % 0.00 % -99.78 % 9 900.00 % -95.78 % -99.54 % 194.06 % -50.00 % 9 900.00 % -99.38 %
5Y -80.00 % -99.66 % -99.00 % 9 900.00 % -99.39 % -99.68 % 87.34 % -98.57 % -50.00 % -99.86 %
10Y -97.78 % -99.88 % -95.71 % 9 900.00 % -99.39 % -99.95 % 84.35 % -99.78 % -99.49 % -100.00 %
Depuis le début -99.88 % -100.00 % -99.90 % 9 900.00 % -99.88 % -100.00 % 331.74 % -99.98 % -99.49 % 13 964.70 %

Dividende

Ligand Pharmaceuticals Incorporated